GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » EV-to-EBITDA

Zahravi Pharmacutical Co (XTEH:DZAH1) EV-to-EBITDA : (As of Jun. 22, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zahravi Pharmacutical Co's enterprise value is IRR0.00 Mil. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Zahravi Pharmacutical Co's EV-to-EBITDA at this moment.

The historical rank and industry rank for Zahravi Pharmacutical Co's EV-to-EBITDA or its related term are showing as below:

XTEH:DZAH1's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.185
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-22), Zahravi Pharmacutical Co's stock price is IRR3681.00. Zahravi Pharmacutical Co does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Zahravi Pharmacutical Co's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Zahravi Pharmacutical Co EV-to-EBITDA Historical Data

The historical data trend for Zahravi Pharmacutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co EV-to-EBITDA Chart

Zahravi Pharmacutical Co Annual Data
Trend
EV-to-EBITDA

Zahravi Pharmacutical Co Semi-Annual Data
EV-to-EBITDA

Competitive Comparison of Zahravi Pharmacutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zahravi Pharmacutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's EV-to-EBITDA falls into.


Zahravi Pharmacutical Co EV-to-EBITDA Calculation

Zahravi Pharmacutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=

Zahravi Pharmacutical Co  (XTEH:DZAH1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zahravi Pharmacutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3681.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Zahravi Pharmacutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » EV-to-EBITDA
Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Website
http://www.zahravi.com
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines